Research study Program year 2025 Source: CMS Open Payments

A Phase 1, Randomized, Dose and Schedule Evaluation Study to Investiga

Research payments

$1,377,389

249 payments

Through program year 2025, $1,377,389 in research payments was reported against A Phase 1, Randomized, Dose and Schedule Evaluation Study to Investiga, across 249 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$157,702	54
2024	Research	$279,851	55
2023	Research	$222,243	31
2022	Research	$348,558	68
2021	Research	$321,767	39
2020	Research	$47,269	2

Breakdown

Who paid Research payments · program years 2020–2025

GlaxoSmithKline, LLC. $1,377,389 249 payments

Who received the money Research payments · program years 2020–2025

Kumc Research Institute INC Organisation paid for research $1,092,252 176 payments
The Charlotte Mecklenburg Hospital Organisation paid for research $130,294 12 payments
University Of Wisconsin And Visual Sciences Organisation paid for research $51,314 19 payments
Yuma Regional Medical Center Specialty Clinics Organisation paid for research $25,444 15 payments
The Charlotte Mecklenburg Hospital Authority Dba Atrium Health Co Organisation paid for research $20,307 1 payment
Wake Forest University Health Scien Organisation paid for research $19,168 5 payments
University Of Wisconsin Organisation paid for research $18,496 13 payments
Ochsner Clinic Foundation Organisation paid for research $16,500 4 payments
Wake Forest University Health Sciences Organisation paid for research $3,614 4 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

4 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.